Improvement of the Chemical Reactivity of Michael Acceptor of Ethacrynic Acid Correlates with Antiproliferative Activities.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
16 Jan 2023
Historique:
received: 07 11 2022
revised: 20 12 2022
accepted: 30 12 2022
entrez: 21 1 2023
pubmed: 22 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

The present study aims to report the design, synthesis, and biological activity of new ethacrynic acid (

Identifiants

pubmed: 36677966
pii: molecules28020910
doi: 10.3390/molecules28020910
pmc: PMC9865193
pii:
doi:

Substances chimiques

Ethacrynic Acid M5DP350VZV
Antineoplastic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Expert Opin Investig Drugs. 2009 Nov;18(11):1735-51
pubmed: 19780706
Cancer Res. 1994 Aug 15;54(16):4313-20
pubmed: 8044778
Cancer Res. 1994 Feb 15;54(4):915-9
pubmed: 8313381
J Am Chem Soc. 2019 May 1;141(17):6864-6868
pubmed: 30998328
Eur J Med Chem. 2019 Jan 1;161:205-238
pubmed: 30359819
BMC Chem. 2022 Jun 24;16(1):47
pubmed: 35751124
Blood. 2014 May 22;123(21):3286-95
pubmed: 24659631
Biochemistry. 1997 Jan 21;36(3):576-85
pubmed: 9012673
Eur J Med Chem. 2016 Oct 21;122:656-673
pubmed: 27448922
Leukemia. 2017 Feb;31(2):340-349
pubmed: 27431016
Expert Opin Investig Drugs. 2014 Jul;23(7):1039-47
pubmed: 24870559
Bioorg Chem. 2021 Oct;115:105293
pubmed: 34426162
Biologics. 2014 Apr 23;8:183-92
pubmed: 24790411
J Chem Inf Model. 2021 Aug 23;61(8):3891-3898
pubmed: 34278794
Chem Soc Rev. 2020 May 21;49(10):3187-3210
pubmed: 32255444
J Am Chem Soc. 2005 Feb 9;127(5):1382-3
pubmed: 15686364
J Biol Chem. 2001 Jun 15;276(24):20999-1003
pubmed: 11279197
Nanoscale. 2015 Mar 7;7(9):3915-22
pubmed: 25503793
Biol Pharm Bull. 2001 Aug;24(8):935-40
pubmed: 11510489
J Med Chem. 2005 Nov 3;48(22):6832-42
pubmed: 16250642
Bioorg Med Chem Lett. 2020 Oct 1;30(19):127426
pubmed: 32755677
Biochem Biophys Res Commun. 2011 Oct 28;414(3):563-8
pubmed: 21982771
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
pubmed: 11259830
BMC Chem. 2021 Dec 20;15(1):66
pubmed: 34930409
Cancer Res. 2000 Aug 1;60(15):4053-7
pubmed: 10945608
J Clin Oncol. 2010 Mar 10;28(8):1301-7
pubmed: 20142587
Bioorg Med Chem. 2006 May 15;14(10):3491-5
pubmed: 16434201
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Adv Drug Deliv Rev. 1997 Jul 7;26(2-3):91-104
pubmed: 10837536
Leuk Res. 2012 May;36(5):598-600
pubmed: 22386728
J Agric Food Chem. 2014 Jun 18;62(24):5538-47
pubmed: 24901506
Chin Med. 2012 Jun 10;7(1):15
pubmed: 22682026
Blood. 2005 Feb 1;105(3):1198-203
pubmed: 15231573
Clin Lung Cancer. 2003 May;4(6):336-8
pubmed: 14599299
Jpn J Cancer Res. 1999 Oct;90(10):1139-45
pubmed: 10595743

Auteurs

Abdelmoula El Abbouchi (A)

Euromed Research Center, Euromed Faculty of Pharmacy, Euromed University of Fes (UEMF), Meknes Road, Fez 30000, Morocco.
Institut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP 6759, CEDEX 2, 45067 Orléans, France.

Nabil El Brahmi (N)

Euromed Research Center, Euromed Faculty of Pharmacy, Euromed University of Fes (UEMF), Meknes Road, Fez 30000, Morocco.

Marie-Aude Hiebel (MA)

Institut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP 6759, CEDEX 2, 45067 Orléans, France.

Hamza Ghammaz (H)

Centre National de la Recherche Scientifique et Technique (CNRST), Angle Avenues des FAR et Allal El Fassi, Hay Ryad, Rabat 10102, Morocco.

Elmostafa El Fahime (E)

Centre National de la Recherche Scientifique et Technique (CNRST), Angle Avenues des FAR et Allal El Fassi, Hay Ryad, Rabat 10102, Morocco.

Jérôme Bignon (J)

Institut de Chimie des Substances Naturelles, CNRS, Université Paris-Saclay, 91190 Gif-sur-Yvette, France.

Gérald Guillaumet (G)

Euromed Research Center, Euromed Faculty of Pharmacy, Euromed University of Fes (UEMF), Meknes Road, Fez 30000, Morocco.
Institut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP 6759, CEDEX 2, 45067 Orléans, France.

Franck Suzenet (F)

Institut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, BP 6759, CEDEX 2, 45067 Orléans, France.

Saïd El Kazzouli (S)

Euromed Research Center, Euromed Faculty of Pharmacy, Euromed University of Fes (UEMF), Meknes Road, Fez 30000, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH